EUVIMEDEUVIMED entdecken
Open Access

PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling

Qing Li, Su-Jie Wang, Wen-Jia Wang, Yu-Cai Ye, Ya-Qin Ling, Ya-Fei Dai

Translational Cancer Research · 2023-03 · 12 (3) · 461-472

DOI: 10.21037/tcr-22-2272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Cancer Research, 2023-03. Verfasst von Qing Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathophysiology, College of Basic Medical Sciences, Lanzhou University, Lanzhou, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

P21-activated kinase 4 (PAK4) involves in cell proliferation in cancer and mutually regulates with p53, a molecule is demonstrated to control cell autophagy by mammalian target of rapamycin (mTOR)/protein kinase B (AKT) signaling. Since the signaling exhibits an association with PAK family members in cell autophagy, it implies that PAK4-relevant proliferation may be impacted by autophagy via p53 with a lack of evidence in cancer cells.

Methods

In this research, transient and stable PAK4-knockdown human hepatocarcinoma cell lines (HepG2) were constructed by transfection of PAK4-RNA interference (RNAi) plasmid and lentivirus containing PAK4-RNAi plasmid, respectively. We investigated cell proliferation using methyl thiazolyl tetrazolium (MTT) and Cell Counting Kit 8 (CCK8) assays, cell cycle by flow cytometry (FCM) and cell autophagy by monodansylcadaverine (MDC) staining and autophagic biomarker's expression, and detected the expressions of p53, mTOR, phosphorylated-AKT (p-AKT) and AKT by immunofluorescence and western blot to explore the mechanism.

Results

We successfully constructed transient and stable PAK4-knockdown HepG2 cell lines, and detected dysfunction of the cells' proliferation. An increased expression of p53, as a molecule of cell-cycle-surveillance on G1/S phase, was demonstrated in the cells although the cell cycle blocked at G2/M. And then, we detected increased autophagosome and autophagic biomarker LC3-II, and decreased expressions in p-AKT and mTOR.

Conclusions

The proliferation is reduced in PAK4-knockdown HepG2 cells, which is relative to not only cell cycle arrest but also cell autophagy, and p53/mTOR/p-AKT signaling involves in the cell progress. The findings provide a new mechanism on PAK4 block in cancer therapy.

Schlagwörter

Stichwörter der Autor:innen

P21-activated kinase 4 (PAK4)autophagycell cyclemammalian target of rapamycin (mTOR)p53

Autor:innen und Institutionen

  • Institute of Pathophysiology, College of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
  • Clinical Laboratory, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, China.
  • Key Laboratory of Ethnomedicine (Minzu University of China), Ministry of Education, Beijing, China.

Zitieren

APA

Li, Q., Wang, S. J., Wang, W. J., Ye, Y. C., Ling, Y. Q., & Dai, Y. F. (2023). PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling. Translational Cancer Research, 12(3), 461-472. https://doi.org/10.21037/tcr-22-2272

Vancouver

Li Q, Wang SJ, Wang WJ, Ye YC, Ling YQ, Dai YF. PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling. Translational Cancer Research. 2023;12(3):461-472. doi:10.21037/tcr-22-2272

BibTeX
@article{Li2023,
  author = {Li, Qing and Wang, Su-Jie and Wang, Wen-Jia and Ye, Yu-Cai and Ling, Ya-Qin and Dai, Ya-Fei},
  title = {PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling},
  journal = {Translational Cancer Research},
  year = {2023},
  volume = {12},
  number = {3},
  pages = {461--472},
  doi = {10.21037/tcr-22-2272}
}
Kostenlos starten →